Patent · US Active

Method system and device for assessing insulin sensitivity

US9244077B2 · kind B2 · utility

5Cited by

2References

18Claims

0Family size

Assignee

Roche Diabetes Care, Inc. · US

Inventors

Ofer Yodfat · Lod, IL
Gali Shapira · Haifa, IL
Iddo Gescheit · Nes Ziona, IL

Key dates

Filing date	Jun 25, 2008
Grant date	Jan 26, 2016
Priority date	—
Expiry date	Nov 2, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/042
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concentration; determining the insulin sensitivity (IS) based on the plasma insulin concentration and the second parameter.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.